EUROPEAN UROLOGY SUPPLEMENTS, vol.10, no.3, 2011 (SCI-Expanded)
Context: The optimal management strategy for clinical stage I (CS1) non-seminomatous germ cell tumors (NSGCTs) of the testis is controversial.